Dawn Attride

Authors up past 60 retractions amid ongoing investigation

A group of researchers in Iran now have had more than 60 papers retracted for concerns about peer review and plagiarism as a publisher investigates its back catalog. One of the researchers, A. Salar Elahi, now ranks 7th on the Retraction Watch Leaderboard.

Previously, Elsevier said they would retract 26 papers from the research group at Islamic Azad University in Tehran for fake reviews in 2017 and 2018. The latest batch of 33 retracted papers originally appeared in Springer Nature’s Journal of Fusion Energy as far back as 2009.

Tim Kersjes, head of research integrity at Springer Nature told us in addition to investigating specific concerns as they arise, his unit also is running “ongoing deep-dive investigations to assess published content that has connections with content that has already been retracted for integrity concerns by ourselves or other publishers.” The recent retractions came from such an investigation that is ongoing, he said.

Exclusive: Prof plagiarized postdoc’s work in now-retracted paper, university found

A political scientist in Canada copied his postdoc’s work without credit in a paper, according to the retraction notice and a university inquiry report.

The paper by Charles Conteh, a professor at Brock University in St. Catharines, Ontario, appeared in Sage’s Outlook on Agriculture in October 2023. It has one citation, according to Clarivate’s Web of Science.

An inquiry by Brock identified plagiarism and uncredited authorship in the article, according to the report finalized this March and seen by Retraction Watch. Failure to give post-doctoral fellows the “opportunity to publish in peer-reviewed journals negatively impacts [them] both reputationally and financially,” the report states.

Giant rat penis redux: AI-generated diagram, errors lead to retraction

In an episode reminiscent of the AI-generated graphic of a rat with a giant penis, another paper with an anatomically incorrect image has been retracted after it attracted attention on social media. The authors admit using ChatGPT to make the diagram.

According to the retraction notice published July 12, the article, by researchers at Guangdong Provincial Hydroelectric Hospital in Guangzhou, China, was retracted after “concerns were raised over the integrity of the data and an inaccurate figure.”

The paper, published in Lippincott’s Medicine, purported to describe a randomized controlled trial that found alkaline water could reduce pain and alleviate symptoms of chronic gouty arthritis.

Did Flint water crisis set kids back in school? Paper saying so is ‘severely flawed,’ say critics

A paper finding kids did worse in school following the Flint water crisis is “severely flawed and unreliable,” according to critics who were deeply involved in exposing the crisis.

The paper has now earned an addendum from the authors, but the critics say it should be retracted.

The authors of the article investigated whether the water crisis in Flint – a period when the drinking water in the Michigan city was contaminated with lead – affected the academic capability of children living there. The authors concluded children in Flint did worse in math after the crisis and more needed special education than before the episode.

The article was published in Science Advances in March and referenced by major news outlets like ProPublica and The Washington Post.

Author blames retraction on ‘Chinese censorship’

A former assistant professor of international relations at Yibin University in Sichuan, China, said he was fired from his job and “forced” to retract a paper on COVID-19 because the article did not “paint a good picture of the Chinese government.”

In the 2021 paper, Thomas Ameyaw-Brobbey, now an adjunct lecturer at Accra Business School in Ghana and an adjunct research fellow at the Ghana Armed Forces Command and Staff College, discussed the negative effects of the pandemic on the global public opinion of Chinese leadership and how the outbreak fostered an “unfavorable image” of China.

After the article appeared in the Journal of International Studies, authorities at Yibin University held several meetings with Ameyaw-Brobbey asking him to explain the paper and why he used a dataset of public opinion in the United States that was “likely to be biased towards China,” he said.

Food science journal retracts 10 papers for compromised peer review

A research group based in Pakistan has had 10 of their papers retracted from Wiley’s Food Science & Nutrition based on flaws in the peer review process.

According to the notices, which were identical for each article, “the editorial office found unambiguous evidence that the manuscript was accepted solely based on compromised and insufficient reviewer reports.”

The following articles have been retracted:

Finland group downgrades 60 journals

A panel of scholars in Finland has downgraded 60 journals in their quality rating system, following months of review and feedback from researchers.

The Finnish Publication Forum (JUFO) classifies and rates journals and other scholarly publications to “support the quality assessment of academic research,” according to its website. JUFO considers the level of transparency, the number of experts on a publication’s editorial board, and the standard of peer review to make its assessment, which academics can use to determine the credibility of a given title or its publisher.

JUFO’s classification ranges from 3, for “supreme-level” publications, to 1, which still counts as legitimate publication. Level 0 means the journal is excluded from the ranking, which may dissuade researchers from publishing with them, James Heathers, a scientific sleuth said. Finland’s university funding model relies on JUFO as a publication quality metric.

Paper recommending vitamin D for COVID-19 retracted four years after expression of concern

A paper that purported to find vitamin D could reduce the severity of COVID-19 symptoms has been retracted from PLOS ONE, four years after the journal issued an expression of concern about the research.

The article, “Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection,” appeared online September 25, 2020. Michael F. Holick, a professor of medicine at Boston University and a proponent of the use of vitamin D, was the last author among a group of other researchers from the Tehran University of Medical Sciences in Iran.

Soon after publication, the paper gained traction on platforms like Twitter (now X) as evidence vitamin D could treat COVID-19 symptoms.

Amidst this discussion, Nick Brown, a science integrity researcher at Linnaeus University in Växjö, Sweden, and Gideon Meyerowitz-Katz, a research fellow at the University of Wollongong, Australia, pointed out potential flaws with the work, including the small sample size of the study and a lack of patient information such as how the patients died.

‘Exhausting’: Author finds another’s name on an Elsevier book chapter she wrote

When Ina Vandebroek read the latest edition of Pharmacognosy, an Elsevier textbook to which she contributed a chapter for the 2017 edition, she was shocked. Although she had declined to write for the 2023 update, her chapter was still in the book, under a different author’s name.

“When I first saw this, it was like somebody hit me on the head with a hammer and everything that I’d worked for all my life was put into question,” Vandebroek, an ethnobotanist and senior research fellow at the University of the West Indies (UWI) in Kingston, Jamaica, told Retraction Watch. “This shakes my foundation of what I think science should stand for.”

The situation arose when one of the textbook’s editors, Simone Ann Marie Badal, a researcher at UWI, asked if Vandebroek wanted to revise her chapter for the new edition. Vandebroek declined, assuming her chapter would be omitted from the book.

Brain tumor researchers lose second paper as UCSF investigates

A research group at the University of California, San Francisco, under investigation for potential misconduct has had a second paper retracted.

The group, led by Russell O. Pieper, director of basic science at the UCSF Brain Tumor Center and vice-chairman of the UCSF Department of Neurological Surgery, previously lost a 2021 paper in Science Translational Medicine after Elisabeth Bik and other commenters on PubPeer posted concerns about some of the images in the article.

The newly retracted paper, “Phosphoglycerate Mutase 1 Activates DNA Damage Repair via Regulation of WIP1 Activity,” appeared in Cell Reports in 2020. It has been cited 25 times, according to Clarivate’s Web of Science.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: